05/30/2026
Recent research being discussed at ASCO 2026 is uncovering a potential new role for GLP-1 medicines in breast cancer care, specifically for managing lymphedema.
In our latest breastcancer.org podcast episode, we sit down with two leaders in the field. They dive into the science behind how these GLP-1 medicines might help reduce the risk of lymphedema by targeting inflammation and metabolic pathways.
Link in comments to follow our ASCO research news page all weekend long for live updates on this and other breaking breast cancer research.